ScholarIQanswers from OpenAlex
The Medical Center of Aurora
InstitutionResearch output, impact & collaborations
The Medical Center of Aurora is a institution indexed in ScholarIQ from OpenAlex.
What is known about The Medical Center of Aurora?
ScholarIQrecord summary
The Medical Center of Aurora is a research organisation in Aurora, US. OpenAlex records 2,280 works and 71,261 citations for it. 886 researchers list it as their most recent affiliation.
How many works does The Medical Center of Aurora have?
ScholarIQindexed works
The Medical Center of Aurora has 2,280 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does The Medical Center of Aurora have?
ScholarIQcitation count
The Medical Center of Aurora has 71,261 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at The Medical Center of Aurora?
ScholarIQresearcher count
The Medical Center of Aurora has 886 researchers in the ScholarIQ index.
What is the average h-index at The Medical Center of Aurora?
ScholarIQavg h-index
The Medical Center of Aurora has an average h-index of 84.2 in OpenAlex.
What is the ROR of The Medical Center of Aurora?
ScholarIQror
The ROR for The Medical Center of Aurora is on the source record.
What is the OpenAlex record for The Medical Center of Aurora?
ScholarIQopenalex
The OpenAlex for The Medical Center of Aurora is on the source record.
What is the Wikidata of The Medical Center of Aurora?
ScholarIQwikidata
The Wikidata for The Medical Center of Aurora is on the source record.
Who are the most-cited researchers behind The Medical Center of Aurora?
ScholarIQtop researchers by citations
What are the most-cited papers on The Medical Center of Aurora?
ScholarIQmost cited works
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Michael G. Silverman, Thomas A. Zelniker, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Christian T. Ruff, Ingrid Gause‐Nilsson, Martin Fredriksson, Peter A. Johansson, Anna-Maria Langkilde, Marc S. Sabatine
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William C. Duckworth, Carlos Abraira, Thomas Moritz, Domenic J. Reda, Nicholas Emanuele, Peter D. Reaven, Franklin J. Zieve, Jennifer A. Marks, Stephen N. Davis, Rodney A. Hayward, Stuart Warren, Steven Goldman, Madeline McCarren, Mary Ellen Vitek, William G. Henderson, Grant D. Huang
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Siân Jones, Xiaosong Zhang, D. Williams Parsons, Jimmy Lin, Rebecca Leary, Philipp Angenendt, Parminder K. Mankoo, Hannah Carter, Hirohiko Kamiyama, Antonio Jimeno, Seung‐Mo Hong, Baojin Fu, Ming‐Tseh Lin, Eric S. Calhoun, Mihoko Kamiyama, Kimberly Walter, Tatiana Nikolskaya, Yuri Nikolsky, James Hartigan, Douglas R. Smith, Manuel Hidalgo, Steven D. Leach, Alison P. Klein, Elizabeth M. Jaffee, Michael Goggins, Anirban Maitra, Christine A. Iacobuzio–Donahue, James R. Eshleman, Scott E. Kern, Ralph H. Hruban, Rachel Karchin, Nickolas Papadopoulos, Giovanni Parmigiani, Bert Vogelstein, Victor E. Velculescu, Kenneth W. Kinzler
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino, Thomas Danne, Richard M. Bergenstal, Stephanie A. Amiel, Roy W. Beck, Torben Biester, Emanuele Bosi, Bruce A. Buckingham, William T. Cefalu, Kelly L. Close, Claudio Cobelli, Eyal Dassau, J. Hans DeVries, Kim C. Donaghue, Klemen Dovč, Francis J. Doyle, Satish K. Garg, George Grunberger, Simon Heller, Lutz Heinemann, Irl B. Hirsch, Roman Hovorka, Weiping Jia, Olga Kordonouri, Boris Kovatchev, Aaron J. Kowalski, Lori M. Laffel, Brian J. Levine, Alexander Yur'evich Mayorov, Chantal Mathieu, Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, KyungAh Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Remo H.M. Furtado, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Marc S. Sabatine
How much of the research on The Medical Center of Aurora is open access?
ScholarIQopen access share
83%OPEN ACCESS